NEW YORK and KFAR SABA, Israel, Nov. 12, 2018 /PRNewswire/ -- CartiHeal, developer of Agili-C, a proprietary implant for the treatment of joint surface lesions, announced today the successful enrollment of the first patient in the Agili-C Investigational Device Exemption (IDE) pivotal study on the East Coast. The surgery was performed by site Principal Investigator Eric J. Strauss, MD, an orthopedic
11-09-2018 / Press release from: Global Market Insights Inc. Cervical artificial disc segment accounted for the largest revenue share of USD 790.1 million in 2017 and is estimated to show significant growth over the forecast period. Cervical disc replacement is a motion preserving surgery and offers benefits over motion creating surgical fusion procedures. According to a clinical
November 08, 2018 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2018. Recent Highlights Total revenue of $5.4 million, including the sale of four
November 08, 2018 CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today provided a business update and reported financial results for the quarter ended September 30, 2018. Richard Toselli, M.D., President and Chief Executive Officer of InVivo, commented, “In the third quarter, we continued to focus efforts on and advance toward our top priority of initiating patient
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today reported financial results and business highlights for the third quarter ended September 30, 2018 and raised its full year 2018 revenue guidance. Third Quarter 2018 Financial Highlights Total
CARLSBAD, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC,” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the relentless pursuit of superior outcomes, today reported financial results for the third quarter ended September 30, 2018 and corporate highlights. Third Quarter
AUDUBON, Pa., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the third quarter ended September 30, 2018. Worldwide sales were $169.2 million, an increase of 11.5% as reported Third quarter net income was $35.2 million, an increase of 37.6% Diluted earnings per share
FARMINGDALE, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, today reported financial results for the fiscal 2019 first quarter ended September 30, 2018 as summarized below: Three Months Ended September 30, 2018 2017 Revenue $ 9,361,164 $
SAN DIEGO, Nov. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use of its COHERE® Porous PEEK™ implant in eXtreme Lateral Interbody Fusion (XLIF®) surgical
CHICAGO, Nov. 8, 2018 /PRNewswire/ -- Active people who are struggling with knee pain or knee cartilage abnormalities may benefit from a Rush University Medical Center clinical trial using an innovative new procedure for cartilage regrowth. Drs. Adam B. Yanke and Brian Cole, orthopedic surgeons and sports medicine physicians at Midwest Orthopaedics at Rush (MOR) are some of the only physicians nationwide conducting clinical trials
